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Three peptides corresponding to glyeine-rieh internal sequences of the guinea pig liver transglutaminase molecule were synthesized. "l'hes¢ were 
peptide 1 (amino acid residues 520-544), peptide 2 (amino acid residues 345-367) and peptide 3(amino acid residues 45-69). All ol" the synthetic 
peptides demonstrated significant binding ability for both ATP and GTP. Peptide 1 was the best protector of transglutaminase ctivity from both 
ATP and GTP inhibition, while peptides 2 and 3 protected the activity only from GTP inhibition, The data shown here lead us to propose putative 
binding site(s) for ATP and GTP guinea pig liver transglutaminase, 
Transglutaminase; Nueleotide binding site 
t. INTRODUCTION 
Transglutaminase (R-glutaminylpeptide:amine ?'-glu- 
tamyltransferase; EC 2.3.2,13) catalyzes an acyl-trans- 
fer reaction between peptidyl glutamine residues and 
primary amines including the e-amino group of lysine 
residues in protein [1,2]. The enzyme distributes widely 
in cells, tissues, body fluids and even in some bacteria 
[1,3,4]. Plasma transglutaminase (Factor XIII) and epi- 
dermal transglutaminase ar  known to be involved in 
blood coagulation [5-7] and formation of the cornified 
envelope in epidermal keratinocytes [8], respectively. 
The physiological function of the tissue or cellular type 
enzyme still remains unresolved. It has, however, been 
postulated to participate in regulation of growth, differ- 
entiation and apoptosis of various cell types [9-14]. 
Recently two groups reported guanine nucleotides 
bind and inhibit tissue type transglutaminase from 
guinea pig liver and human erythrocyte [15,16]. We re- 
ported that the same enzymes demonstrated GTP hy- 
drolysis activity [17]. We found that guinea pig liver 
enzyme hydrolyzed ATP as well (manuscript in prepa- 
ration). Thus, it is significant to determine the site(s) for 
nucleotide binding to better understand the structure- 
function relationship of tissue transglutaminase. 
We hypothesize that internal sequences in guinea pig 
liver transghttaminase molecule (amino acid residues 
520-544, 345-367, and 45-69; [18]) are possible nucleo- 
tide binding sites because of their high glycine contents 
(see Table I and [19-23]). To test this hypothesis, we 
synthesized peptides corresponding to these amino acid 
residues. The synthetic peptides blotted to nitroceUulose 
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membrane-bound 3:P-labeled ATP and GTP. Further- 
more, the first peptide with amino acid residues 520- 
544 protected the transglutaminase activity from both 
ATP and GTP inhibition, while the second and third 
peptides howed their protective ffect only on GTP 
inhibition. These observations uggest that the se- 
quences are related to nucleotide binding. The results 
described here, in conjunction with previous reports 
[15-17], suggest an important physiological role of 
transglutaminase whose function is directly regulated 
by nueleotides. 
2. MATERIALS AND METHODS 
ATP and GTP were purchased from Sigma. [~-'~:P]ATP and 
[cz-~-'PIGTP were purchased from New England Nuclear. Guinea pig 
liver transglutaminase was parifi~l to homogeneity from a commer- 
cial source (Sigma) by GTP-agarose affinity ¢hrontatography, as de- 
scribed [17], The purified enzyme was stored in aliquots at -700C. 
Protein concentrations were determined by the Bradford method [-24 I.
The transgluhaminase ctivity was measured for 20 rain at 37°C in 
0.2 ml of 40 mM Tris-HCl (pH 7.5)/150 mM NaCI (TBSI in i'.~g 
presence of 200/tM CaCI: and 40 #M ED'rA (thus ~ 160/JM free Ca-") 
and 10 mM dithiothreitol as reported [25] using 1 mM [l.4-taClpu - 
tr~.~seine (spee. act. i/.tCi/~mol; Amerslmm) and 0.5 nag N,N-dimethyl- 
ated casein (Calbioehem). ATP and GTP were pre~ent in the assay 
mixture at the indicated concentrations. The time course of the r~_ae- 
tion was linear up to 40 rain. 
Based on the cloned sequence reported [18]. peptide~ with internal 
sequences of guinea Pi13 liver transglutaminas¢ were synth~ized by Dr. 
K. Jack,on (Saint Francis Hospital of Tulsa. Medical Research Insti- 
tute. University of Oklahoma, Oklahoma City) by F-moc peptid¢ 
synth~is trategy [26] utilizing a DaPont ramps system and were 
purified by reverse-phase HPLC on a column of Synehropak gP-P 
C-18 (22.5 × 250 ram, Synchrom Inc., Linden, IN) using a linear 
gradient of 0.1% trifluoroa~tic a id in H,O and 0.08% in acetonitrile 
[27], Peptides ynthesized and used in this study are list,'d in Table !. 
The aqueous olution of synthetic peptides was adjmt~l to pH ~7.5 
with Trizma ba.~e and HCI. 
To detect their nucleotide binding activity, 10 nmol ofeach peptide 
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Fig. 1. Nucleotide inhibition of the transglutaminase ctivity. Transglutaminase ctivity was assayed with 0.2B/.tg enzyme in the presence of200 
/.tM CaCl: and 40/~M EDTA (thus -160/~M free Ca-'*) plus various concentrations ofGTP (I) or ATP (o). Values represent mean _+ S.ILM. from 
4-8 experiments. The abscissa of Figs. 1 and 2 are in logarithmic ~cale. Arrows indicate the concentrations of GTP (0.5 #M) and ATP (500/~M) 
that were used in the experiments forTable 1I and Fig. 2, 
were spotted onto nitrocellulose membrane (Schleieher & Schuell) 
which was prewetted in H.,O, In order to mininaize the non-specific 
binding of nueleotides to the membrane, the membrane was preincu- 
bated with 3% (w/v) BSA in TBS for 3 h at room temperature and was 
further incubated at 37°C for 30 rain in 5 ml of TBS containing 500 
/.tM [nP]ATP (spec. act. 100 #Ci/#mol) or0.SpM [nP]GTP (sp¢¢. act, 
2,000 #Ci/~mol), and 200/~M CAC1440/.tM EDTA (+ Ca condition) 
or 40,aM EDTA (- Ca condition). The nitrocellulose membrane was 
then washed 3 times with 5 mi of ice-chilled, corresponding buffer 
which did not contain BSA or nu¢leotides. The membrane was dri~ 
in air and measured for radioactivity. Purified guinea pig liver 
transglutnminase (10/.tg) was processed ina similar manner. 
To test he ability of synthetic peptides to protect the transglutam- 
inase activity from nucleotide inhibition, each peptide was preincu- 
bated with ATP or OTP for 10 rain at 37°C in 90/~1 of TBS (40 raM 
Tris-HCI/150 mM NaCI, pH 7.5) containing Ca:'_ Following the addi- 
tion of enzyme (0,2B 128) and substrates (['~C]putre~cine plus dimeth- 
yleasein), tho mixture was asgayed for transglutaminase activity in 200 
#1 of TIIS [25J, Final ~ncentrations of free Ca:*, ATP and GTP were 
160 #M, 500 #M and 0.5 #M, respectively, and those of the peptides 
are indicated in Fig. 2. None of the peptides possessed any transglu- 
taminase activity or were substrates for tran~glutaminase. 
3. RESULTS 
GTP was reported to be a potent inhibitor of  tissue 
transglutaminase [15,16]. Fig. I illustrates that ATP is 
also inhibitory to guinea pig liver transglutaminase but 
at ,,-103-fold higher concentration compared to GTP 
(ICs0s of  ATP and GTP were ---5.3 × 10 -4 M and -.-5,7 
x 10 -7 M, respectively), Guinea pig liver enzyme hydro- 
lyzes GTP [17] as well as ATP (manuscript in prepara- 
tion, see Introduction). Thus, the enzyme should con- 
tain nueleotide binding site(s). While the amino acid 
sequence deduced from cloned eDNA [18] did not rep- 
resent any typical consensus motif for nucleotide bind- 
ing, such as-G-X-G-X.,.-G-[19-21] or G-X4-G-K 
[22,23] (Xs are nonconservative r sidues, subscipts are 
the number of intervening residues, and the third Gly 
of-G-X-G-X:-G- may be replaced by Ser or Ala in some 
protein kinases), we selected internal sequences of 
guinea pig liver enzyme lbr possible nucleotide binding 
sites based on glyeine-rieh regions, Peptides corre- 
sponding to these sequences were synthesized as listed 
in Table I. 
Table II demonstrates that peptides l, 2 and 3 which 
carried glycine-rich sequences bound both ATP and 
GTP. Peptide 4, a glycine-rich peptide based on the 
eDNA clone of human endothelial transglutaminase 
[28], also showed nucleotide binding, In contrast, pep- 
tide 5 which carried no such sequence showed no bind- 
ing of the nucleotides. The ability of synthetic peptides 
to bind nucleotides was not related to their content of 
charged amino acids, However, Ca'-* decreased both 
ATP binding and GTP binding to peptide 2 (P <0.01 in 
Student's t-test), perhaps uggesting another egulatory 
role of Ca-'* in the biochemical process which transglu- 
taminase is involved in. 
The nucleotide binding ability of  the intact enzyme 
molecule was much greater than that of  its partial pep- 
Table I
Peptides ynthesized and used in this study 
Peptide* Amino acid sequence** Position in parental molecule 
1 N-G-V-L -G-P -V -C-S -T -N-D-L -L -N-L -T -L -D-  P- F -S-E-N-S  520-544 
_9 A-G- P -G-A-W-V-R-G-V-Q-A-  L-D- P-T- P-Q-E-K- S- E-G 345-367 
3 E-G- R -G-Y -E -A -G-V-  D-T- L -T -F -N-A-V-T -G-  P-D- P- S-E-E 45- 69 
4 L -K -N-A-G-R-D-C-S -  R-R-S-  S- p -V-Y-V-G-R-V-G-  S-_G-M 204-227 
5 K- I -S -T -K -S -V~G-R-  D- E- [~-E-D- I -T -H-T -Y -K  424-443 
*Peptides 1-3 and 5 are deduced from eDNA sequence ofguinea pig liver transglutaminase [18], while peptide 4 is deduced from eDNA sequence 
of human endothelial trans~lutaminase [28].Pcptide 5 was selected as a control. 
**Single letter code was employed, The underlined amino acids are suggested to be key residues for possible nttcleotide binding [19-23]. 
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Fig. 2, Protection of the trans$1utaminas¢ ctivity from nucleotide inhibition by synthetic peptides, Peptide 1 (o), 2 (e), 3 (n), 5 (×) and peptide 
4 (&) were corresponding to amino acid residues 520-544, 345-367, 45-69 and 424-443 of guinea pig liver transglutaminase 1"18] and residues 204-227 
of human endothelial transglutaminase [28], respectively, Activities obtained from 4-6 experiments were plotted as % of control assay which 
contained neither nueleotide nor synthetic peptide. The figure shows the recovery of transglutarninase ctivity by peptides from 500 ItM ATP 
inhibition (A) and 0.5 pM GTP inhibition (B), respectively. "Significantly different (P<0.02. Student's t-test) from no peptide sample, 
tides (Table II), probably because of the sustained 
higher structure of nucleotide binding sequence in the 
intact enzyme. 
Since both GTP and ATP inhibited the transglutami- 
nase activity of guinea pig liver enzyme (Fig. 1) and 
Table II 
Nucleotide binding to peptides 
Nucleotide Pcptide Nueleotide bound (fmol/nmol 
peptide) 
+Ca -Ca 
ATP 
GTP 
1 452 _, 38 351 ± 17 
2 275 _'/" 4 156 _+ 26" 
3 343 __. 9 335 +_ 40 
4 228 5: 11 245 + 6 
5 37 _+ 9 10 + 28 
Puritied trans- 64,260 +_ 4,680 56,170 + 1,280 
glutaminase 
1 25.3 + 1,1 24.7 + 1.6 
2 15,3 _ 0,5 6,4 + 2.0" 
3 20,0 +_ 1,4 21.4 _+ 1.8 
4 13,5 ~ 1,3 IL6 + 1.5 
5 -2,5 _+ 0,4 1.0 _+ 1.2 
Purified trans- 3,690 _.2 251 4,081 __. 773 
slutaminase 
Values were expressed as mean + S.E,M. from 4--6 experiments, Stu- 
dent's t-test between a value for peptide 5 and values for any other 
peptides demonstrated a statistical difference with P<0.001, with two 
exceptions under a -Ca =÷ condition as designated by" and "" ( "P<0,01 
betw~n peptide 2 and 5; "no significant difference between peptidc 
2 and 5), ° and"  also indicate that a -Ca a" condition &'creased both 
ATP and GTP binding to peptide 2 (P<0.01, between +Ca and -Ca 
samples). Values cannot be compared between ATP and GTP, since 
different nucleotid~ concentrations (500/aM ATP and 0.5/aM GTP) 
were employed in this exr~rim~nt according to their different inhib- 
itory mode as shown in Fig. I. 
synthetic peFtides which encompassed glycine-rich re- 
gions of the enzyme molecule were capable of binding 
nucleotides (Table IlL we supposed that these peptides 
could release the transglutaminase ctivity from nucleo- 
tide inhibition. As shown in Fig. 2, peptide 1 signifi- 
cantly protected the transglutaminase activity from 
both ATP and GTP inhibition, while peptides 2 and 3 
gave protection only against GTP inhibition. Peptide 5 
which contained no glycmc-rich sequence had no effect 
on GTP and ATP inhibition. The concentration f the 
synthetic peptide (1 mM, the molar ratio to the enzyme 
was 57,000:1) required for an efficient protection may 
indicate some additional sequence is also involved in 
nucleotide binding in the intact enzyme molecule (see 
Discussion). It is interesting to note that peptide 4 de- 
rived from endothelial transglutaminase [28] protected 
guinea pig liver enzyme activity from GTP inhibition 
(Fig. 2B). This suggests that the endothelial enzyme is 
also regulated by GTP. 
4. DISCUSSION 
Peptides that contained glycine-rich sequences [19- 
23] were synthesized to study the nucleotide binding 
sites in guinea pig liver transglutaminase molecule 
(Table I). All such peptides demonstrated ATP and 
GTP binding, while peptide 5, which did not carry a 
glycine-rich sequence, showed no nucleotide binding 
(Table II). Among these peptides, peptide 1was the best 
at protecting against both ATP and GTP inhibition 
(Fig. 2). This coincides with the highest nucleotide bind- 
ing ability of peptide 1 in the presence of Ca"*, com- 
pared to that of other peptides (Table II, and note that 
transglutaminase ctivity was assayed in the presence of 
Ca2*). Peptides 2--4 protected the enzyme activity from 
GTP inhibition, but not from ATP inhibition, while 
179 
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peptide 5 with no glycine-rich sequence did not show 
any protection against ATP or GTP inhibition (Fig. 2). 
Although none of the peptides match well with the ca- 
nonical consensus motif for nuc!eotide binding [19-23], 
Table II and Fig. 2 suggest hat peptides 1-4 which have 
g!ycine-rich sequences are related to the internal se- 
quences for nucleotide binding. Thus, we propose that 
guinea pig liver transglutaminase contains at least three 
nucleotide binding sites, which correspond to peptides 
1-3 listed in Table I. 
When nitrocellulose membrane was not blocked with 
BSA prior to ATP binding assay, the experimental er- 
rors were large compared to those shown in Table II. 
However, ATP binding to peptides 2--4 was decreased 
to one-fifteenth, one-third and one-fifth, respectively, of 
that seen with peptide 1. This may explain the failure of 
peptides 2-4 to recover the ATP-inhibited transglutam- 
inase activity (Fig. 2A, and note that BSA was not 
included in the enzyme assay). GTP binding to peptides 
was not significantly influenced by omitting the BSA 
blocking step (data not shown). 
It is interesting to note that the amino acid sequence 
of guinea pig liver enzyme deduced fi'om eDNA clone 
[18] shows DDQG (residues 231-234) and DQAG_Q(resi- 
dues 343-346) that match with the second consensus 
motif for nucleotide binding (element II, designated as 
DX,G; [29]), while a sequence DAPI_G__ (residues 108- 
112) is element II-like. One of these sequences may cou- 
ple with residues 45-69 (peptide 3) in nucleotide bind- 
ing. 
We have proposed possible ATP and GTP binding 
sites based on the data shown in Table II and Fig. 2. 
However, these sites still remain to be established, since 
it is important to determine their affinities for nucleo- 
tides in the intact enzyme molecule. Ca 2÷ appears to be 
an additional factor in this regard, as the divalent cation 
modified the nucleotide binding ability of peptide 2 
(Table II). It is also important to determine which nu- 
cleotide site is involved in the nucleotide hydrolysis ac- 
tivity of guinea pig liver transglutaminase [17]. Various 
approaches must be taken to clarify the structure-func- 
tion relationship of this multifunctional enzyme and its 
regulation. 
After this work was completed, purified rat liver 
transglutaminase was reported to be inhibited more ef- 
fectively by ATP than by GTP [30], contrary to the 
previous reports [15,16] as well as this report (Fig. 1). 
Tissue type transglutaminase from different sources 
may have different sensitivity to nucleotides. 
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